An observational study in Stroke, Cerebral Infarction and Transient Ischemic Attack, sponsored by Yefeng Cai. Status unknown at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-03-08.
Sponsored by Yefeng Cai · Observational
Stroke is the first most common cause of death in China and one of the major causes of functional disability in the adult population.The burden of stoke is significantly increased in China in recent years.
In order to investigate the prognosis of stroke, with diagnostic and treatment information of traditional Chinese medicine (TCM), and assess the effectiveness and safety of TCM for stroke in southern China, the investigators will conduct this multicenter prospective registry study in southern China. This study will recruit 10,000 consecutive eligible patients with acute stroke from more than 50 hospitals. 24 months follow-up will be carried out on-site in hospitals and by telephone to track endpoint (including all-cause mortality, composite cerebrovascular and cardiovascular events at one and two year follow up, and neurological and functional assessments).
219 studies on the registry are indexed under Cerebral Infarction; 46 are open to participants now.
This study's planned enrollment of 10,000 is above the median of 335 across 72 observational studies indexed under Cerebral Infarction.
Browse Cerebral Infarction studies →This is the only study on the registry with Yefeng Cai as lead sponsor.
Compared within Cerebral Infarction, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Stroke. The counts are of registry records indexed under each term, refreshed daily. How we classify →
The study population will be comprised of those who meet all inclusion criteria and no exclusion criteria. Study personnel will continuously screen eligible patients presenting to the hospitals until the sample size of 10000 is reached. This study will be conducted in more than 50 hopitals in southern China.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.
Stroke symptoms need emergency care at once, even if they go away.
TIA (transient ischaemic attack)
A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.
Stroke symptoms need emergency care at once, even if they go away.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Stroke patients who treated by western medicine and/or traditional Chinese medicine in southern China
Other: observational only-no intervention
Observational only and no predesigned interventions in this study.
All-cause mortality
Time frame: 12 months follow-up
Composite cerebrovascular and cardiovascular events
Including stroke recurrence events,acute myocardial infarction and cardiac death
Time frame: 12 months follow-up
All-cause mortality
Time frame: 24 months follow-up
Composite cerebrovascular and cardiovascular events
Including stroke recurrence events,acute myocardial infarction and cardiac death
Time frame: 24 months follow-up
Modified Rankin Scale(mRS)
Range:Grade 0 to Grade 6, higher grade represent a worse outcome
Time frame: 3 months follow-up
Barthel Index(BI)
Range:0 to 100 points, higher points represent a better outcome
Time frame: 3 months follow-up
Mini-Mental State Examination(MMSE)
Range:0 to 30 points, higher points represent a better outcome
Time frame: 3 months follow-up
Modified Rankin Scale(mRS)
Range:Grade 0 to Grade 6, higher grade represent a worse outcome
Time frame: 12 months follow-up
Barthel Index(BI)
Range:0 to 100 points, higher points represent a better outcome
Time frame: 12 months follow-up
Mini-Mental State Examination(MMSE)
Range:0 to 30 points, higher points represent a better outcome
Time frame: 12 months follow-up
Modified Rankin Scale(mRS)
Range:Grade 0 to Grade 6, higher grade represent a worse outcome
Time frame: 24 months follow-up
Barthel Index(BI)
Range:0 to 100 points, higher points represent a better outcome
Time frame: 24 months follow-up
Mini-Mental State Examination(MMSE)
Range:0 to 30 points, higher points represent a better outcome
Time frame: 24 months follow-up
This study is status unknown, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.